.fremanezumab has completed phase iii trials and is under review by the fda to prevent migraine and.
while all of the drugs work on cgrp, they don�t all work the same way. three of them target the cgrp molecule itself. aimovig goes after cgrp's receptor in the brain.. the latest figures mean that since january 2000, scottish widows has paid a total of £2.5bn in claims to more than 86,000 customers...